COMMUNIQUÉS West-GlobeNewswire

Centre for Neuro Skills Expands Employer Partnerships Strategy, Appoints Jay Varma as Director
18/03/2026
CNS strengthens its engagement with employers, health plans and benefits advisors to expand access to specialized neuro center of excellence BAKERSFIELD, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Centre for Neuro [...]
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
18/03/2026
Advancing t ransformation into a d iversified b iomedical i nnovation c ompany with a c lear p ath to c ash f low p ositiv e Oramed s trategic t ransaction r eceives s hareholder a pproval ; Lifeward g ain s n ew o ral [...]
Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commercial Scale
18/03/2026
DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- www.247marketnews.com -- A biotechnology company developing genetically engineered silkworms says it’s moving toward commercial production of spider silk, a material long [...]
Cortisol Detox App Supports Healthy Fat Loss With Meal Plans and Mindfulness
18/03/2026
Cortisol Detox Combines Anti-Cortisol Diet, Workouts, and Meditation to Support Weight Loss NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Cortisol Detox offers a personalized weight-loss program designed to help [...]
Pliant Therapeutics Announces Upcoming Presentation of Phase 1 Clinical Trial of PLN-101095 in Patients with Solid Tumors at the 2026 AACR Annual Meeting
18/03/2026
Selected for oral presentation at Clinical Trials Mini Symposium SOUTH SAN FRANCISCO, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused [...]
LiveWorld Reports 2025 Financial Results
18/03/2026
LiveWorld continues to increase its AI investment CAMPBELL, Calif. and NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), today announced financial results for the year 2025. Twelve Months [...]
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
18/03/2026
— The lowered pricing structure is now available for 963,88 SEK per bottle at pharmacies throughout Sweden AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company [...]
OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights
18/03/2026
MINNEAPOLIS, March 18, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-ready Real-World Data (RWD [...]
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
18/03/2026
• Baylor selects the Nautilus Voyager™ Platform, now available through Early Access Program, for development of a first-in-class computational multi-omics toolkit • NIH-funded project leverages collaborators’ expertise [...]
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
18/03/2026
— The lowered pricing structure is now available for 101.82 EUR per bottle at pharmacies throughout Finland AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company [...]
Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative
18/03/2026
PacBio’s Revio system and SPRQ-Nx chemistry to enable an order-of-magnitude expansion of HiFi metagenomic sequencing for scaling AI-designed therapeutics MENLO PARK, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- PacBio ( [...]
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
18/03/2026
— The lowered pricing structure is now available for 798,86 DKK per bottle at pharmacies throughout Denmark AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company [...]
JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System — the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR) in the United States
18/03/2026
Approval marks a historic milestone for Americans living with ssAR who are at high risk for surgery and previously had no dedicated transcatheter treatment option IRVINE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- [...]
Amphista Therapeutics appoints Louise Modis Ph.D. as CEO and Patrick Kelly M.D. as CMO and provides a business update as the Company prepares to file IND application for AMX-883
18/03/2026
Strengthening the clinical leadership as the Company progresses to the clinic with its BRD9 Targeted Glue™, AMX-883, in acute myeloid leukemia Amphista continues to advance its SMARCA and TEAD programs to key inflection [...]
Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate
18/03/2026
AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio’s purpose-built agentic AI platform for the biotechnology industry TORONTO and ARLINGTON, Mass [...]
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
18/03/2026
— The lowered pricing structure is now available for 16.984 ISK per bottle at pharmacies throughout Iceland AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company [...]
Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study
18/03/2026
Investigator-sponsored trial backed by Glaucoma UK and HSC R&D Division targets rapidly growing patient population; first enrollment expected Q2 2026 BRISTOL, Tenn., March 18, 2026 (GLOBE NEWSWIRE) -- Artelo [...]
Arcutis to Present New Clinical Data in a Late-Breaking Podium Presentation and Scientific Posters at the 2026 American Academy of Dermatology Annual Meeting
18/03/2026
WESTLAKE VILLAGE, Calif., and DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno- [...]
SRx Health Solutions Hedges Investments in Cryptocurrency and Emerging Markets for Volatility Protection
18/03/2026
The Company will update shareholders in the near future on the proposed timing to close the EMJX transaction NORTH PALM BEACH, Fla., March 18, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) ( [...]

Pages